发明名称 Sustained-release preparation
摘要 Provided is a sustained-release preparation containing pioglitazone or a salt thereof as an active ingredient and showing superior sustainability. A sustained-release preparation containing pioglitazone or a salt thereof, which shows a dissolution ratio of pioglitazone of average 25-58% at the 2-hour time point, and average 60-100% at the 4-hour time point, in a dissolution test according to the 50 rpm USP Paddle Method and using pH 2.0 KC1/HC1 buffer at 37°C as a test solution. In one example, the sustained-release preparation comprises pioglitazone or a salt thereof, polyethylene oxide and a gel forming promoter.
申请公布号 NZ624275(A) 申请公布日期 2016.09.30
申请号 NZ20120624275 申请日期 2012.10.19
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 TANOUE YUTAKA;ISHII YUMIKO;MURAKAWA YUSUKE;TAKENAKA KAORU
分类号 A61K9/20;A61K31/4439 主分类号 A61K9/20
代理机构 代理人
主权项
地址